Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel Brungs"'
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 962-967 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 962-967 (2020)
Non-small cell lung cancer (NSCLC) is characterised by diffuse metastases, with common sites being the brain, liver, bones, and adrenal glands. Small bowel metastasis from NSCLC is a rare phenomenon, particularly in patients with an adenocarcinoma hi
Autor:
Boris Kasparov, Philip Clingan, Natalia Fadeeva, Andrey Akopov, Margaret McGrath, Vasiliy Oschepkov, Vadim Kozlov, Arunee Dechaphunkul, Virote Sriuranpong, James Oliviero, D. Harris, Fedor Moiseenko, Andrea Tazbirkova, Piotr Koralewski, Chaiyut Charoentumn, Iwona Lugowska, Nadezhda Kovalenko, Dariusz Kowalski, Daniel Brungs, Andrew Mant, Rahul Ladwah
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Cosibelimab is a high affinity, fully-human IgG1 monoclonal antibody that directly binds to programmed death ligand-1 (PD-L1) and blocks its interaction with the programmed death receptor-1 (PD-1) and B7.1 receptors to restore an anti-tumo
Publikováno v:
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Clinical Medicine Insights: Oncology, Vol 14 (2020)
Objectives: Central venous access is needed to facilitate chemotherapy for many cancer patients. Central venous catheter-related thrombosis (CVCT) is a major complication that can cause significant morbidity and mortality. We sought to explore the ra
Autor:
Po Yee Yip, Deme Karikios, Dariush Daneshvar, Rebecca Asher, Tamkin Ahmadzada, Nick Pavlakis, Helen Westman, Vesna Aleksova, Elham Hosseini-Beheshti, Stephen Clarke, Daniel Brungs, Anthony J. Gill, Mikaela Holmes, Wendy A Cooper, Juliet Burn, Ina Nordman, Steven Kao, Abhijit Pal, Glen Reid, Robert Zielinski, Adnan Nagrial, Annabelle Mahar, Georges E. Grau
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 4, Pp 100075-(2020)
JTO Clinical and Research Reports
JTO Clinical and Research Reports
Introduction: We investigated the efficacy and toxicity of pembrolizumab in patients with mesothelioma from a real-world Australian population. We aimed to determine clinical factors and predictive biomarkers that could help select patients who are l
Autor:
Joey Yusof Vessey, Renata Bazina, Mathias Jaeger, Celine Garrett, Eng-Siew Koh, Daniel Brungs, David A. Lynch, Mark Sheridan, Therese M. Becker, Adam Cooper, Branka Powter, Tara L. Roberts, Joseph W. Po, Balsam Darwish, Paul de Souza, Heena Sareen, Simon Mckechnie, James M. van Gelder
Publikováno v:
Cancers, Vol 12, Iss 1831, p 1831 (2020)
Cancers
Cancers
Glioblastoma multiforme (GBM) is one of the most lethal primary central nervous system cancers with a median overall survival of only 12–15 months. The best documented treatment is surgical tumor debulking followed by chemoradiation and adjuvant ch
Autor:
June Rose, Wei Chua, Martin G Carolan, Tameika Tubaro, Emma Healey, Morteza Aghmesheh, Weng Ng, Phillip R Clingan, Marie Ranson, Daniel Brungs, Paul de Souza
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
BMC Cancer
BMC Cancer
Background/Aim Right sided colon cancer (RsCC) is proposed to be a distinct disease entity to left sided colon cancer (LsCC). We seek to confirm primary tumour location as an independent prognostic factor in locoregional colorectal cancer. Methods Al